Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
IgG4-Related Disease
Do you generally request IgG4 staining on all of your salivary gland biopsies in seronegative patients presenting with dry mouth?
Related Questions
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
In a patient with prior biopsy-proven IgG4-related pachymeningitis who develops recurrent neurologic symptoms years after discontinuing immunosuppression, how do you determine whether this represents relapse versus alternative etiologies?
When evaluating a patient with IgG4-related disease, are there particular exposures or risk factors you routinely ask about during the history to help identify potential contributors?
For suspected IgG4-RD, what imaging modality do you use in your practice for initial diagnostic evaluation?
How would you approach a patient with history of cocaine use presenting with chronic sinusitis and acute vision loss from an extensive inflammatory changes in the sinus and orbit compressing the optic nerve with negative ANCA, inconclusive nasal biopsy and elevated serum IgG4?
How do you approach management of a patient with a retroperitoneal soft tissue mass and elevated IgG4 level when tissue biopsy is not feasible?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
How do you approach management of a patient with psoriasis and chronic anterior uveitis who is unable to take DMARDs and has tried TNF inhibitor and IL-17 inhibitors but has ongoing bilateral anterior uveitis?
Do you wait until serum anti-GBM antibody titers are undetectable before hospital discharge in a patient with anti-GBM antibody disease with renal involvement who is receiving daily plasmapheresis, cyclophosphamide, and steroids?
